Mackenzie Financial’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Buy |
28,390
+9,274
| +49% | +$400K | ﹤0.01% | 960 |
|
|
2025
Q1 | $661K | Buy |
19,116
+9,611
| +101% | +$332K | ﹤0.01% | 1105 |
|
|
2024
Q4 | $261K | Buy |
9,505
+592
| +7% | +$16.2K | ﹤0.01% | 1442 |
|
|
2024
Q3 | $227K | Buy |
+8,913
| New | +$227K | ﹤0.01% | 1322 |
|
|
2024
Q2 | – | Sell |
-6,992
| Closed | -$216K | – | 1546 |
|
|
2024
Q1 | $216K | Hold |
6,992
| – | – | ﹤0.01% | 1307 |
|
|
2023
Q4 | $282K | Buy |
+6,992
| New | +$282K | ﹤0.01% | 1180 |
|
|
2021
Q4 | – | Sell |
-6,277
| Closed | -$294K | – | 1438 |
|
|
2021
Q3 | $294K | Buy |
6,277
+2,625
| +72% | +$123K | ﹤0.01% | 1146 |
|
|
2021
Q2 | $223K | Buy |
+3,652
| New | +$223K | ﹤0.01% | 1138 |
|